Hydroxycarbamide/didanosine: increased risk of pancreatitis in HIV

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2001年 / 858卷 / 1期
关键词：
Pancreatitis; Zidovudine; Hydroxyurea; Didanosine; Stavudine;
D O I：
10.2165/00128415-200108580-00011
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5 / 5
相关论文
共 50 条
  • [1] Hydroxychloroquine, hydroxycarbamide, and didanosine as economic treatment for HIV-1
    Paton, NI
    Aboulhab, J
    Karim, F
    [J]. LANCET, 2002, 359 (9318): : 1667 - 1668
  • [2] Didanosine interactionFirst report of an interaction with concomitant hydroxycarbamide leading to pancreatitis: case report
    [J]. Reactions Weekly, 2001, 835 (1) : 8 - 8
  • [3] Hydroxycarbamide + didanosine is well tolerated in asymptomatic HIV-positive patients
    [J]. Reactions Weekly, 1999, 780 (1) : 5 - 5
  • [4] Low risk of pancreatitis in HIV-infected patients on hydroxyurea plus didanosine
    Barreiro, P
    Soriano, V
    Valencia, E
    Díaz, B
    González-Lahoz, J
    [J]. AIDS, 2001, 15 (18) : 2469 - 2470
  • [5] Risk of peripheral neuropathy increased with hydroxycarbamide
    [J]. Reactions Weekly, 2000, 800 (1) : 4 - 4
  • [6] 1-year follow-up of the use of hydroxycarbamide and didanosine in HIV infection
    Vila, J
    Biron, F
    Nugier, F
    Vallet, T
    Peyramond, D
    [J]. LANCET, 1996, 348 (9021): : 203 - 204
  • [7] Absence of viral rebound after treatment of HIV-infected patients with didanosine and hydroxycarbamide
    Vila, J
    Nugier, F
    Bargues, G
    Vallet, T
    Peyramond, D
    HamediSangsari, F
    Seigneurin, JM
    [J]. LANCET, 1997, 350 (9078): : 635 - 636
  • [8] Didanosine + tenofovir df increases pancreatitis risk
    [J]. Reactions Weekly, 2004, 1009 (1) : 4 - 4
  • [9] Pancreatitis with coprescription of antiretroviral agents, ribavirin and interferonα: increased didanosine toxicity?
    Moachon, L.
    Salmon-Ceron, D.
    Abad, S.
    Bavoux, F.
    Vauzelle, C.
    Loubeyre, C.
    Sicard, D.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 27 - 27
  • [10] RISK-FACTORS FOR PANCREATITIS IN PHASE I TRIALS OF DIDANOSINE
    GRASELA, TH
    WALAWANDER, CA
    BELTANGADY, M
    KNUPP, CA
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (02) : 126 - 126
12345